Lv4
780 积分 2025-03-13 加入
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
12小时前
待确认
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors
1个月前
已完结
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
1个月前
已完结
OUP accepted manuscript
1个月前
已完结
Trends in clinical success rates and therapeutic focus
2个月前
已完结
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence
2个月前
已完结
The impact of accelerated drug marketing registration procedures on the review and approval of new drugs in China
2个月前
已完结
The impact of accelerated drug marketing registration procedures on the review and approval of new drugs in China
2个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
2个月前
已完结
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
3个月前
已完结
皖公网安备34019202002308
